Sartorius Stedim Biotech SA
PAR:DIM

Watchlist Manager
Sartorius Stedim Biotech SA Logo
Sartorius Stedim Biotech SA
PAR:DIM
Watchlist
Price: 184.3 EUR -0.81% Market Closed
Market Cap: 17.9B EUR
Have any thoughts about
Sartorius Stedim Biotech SA?
Write Note

Sartorius Stedim Biotech SA
Investor Relations

Sartorius Stedim Biotech SA has been weaving the intricate threads of biotechnology innovation into a fabric of global influence and success. Established as a pivotal player in the biopharmaceutical industry, Sartorius Stedim Biotech has carved out a niche by offering sophisticated products and solutions that cater to the unique needs of biopharmaceutical manufacturers. The company’s portfolio is a testament to the fusion of scientific ingenuity and relentless pursuit of quality. Spanning filtration and purification solutions, fermentation equipment, and fluid management systems, their offerings ensure that complex biological drugs, including vaccines and monoclonal antibodies, are produced efficiently and safely. Sartorius Stedim Biotech’s endeavor is not just about supplying equipment; it’s about providing integrated solutions that optimize the entire production process, ensuring consistency, scalability, and compliance in industries bound by strict regulatory oversight.

The company generated revenue through its comprehensive range of products and services that address every step of the biomanufacturing process. Their business model hinges on fostering long-term relationships with clients by offering tailored solutions that enhance productivity and reduce time-to-market for new therapies. Beyond direct sales of high-value equipment, Sartorius Stedim Biotech also capitalizes on recurring revenue streams generated from consumables and maintenance services essential for the ongoing operation of their systems. By continuously innovating and expanding its product lines, the company stays at the forefront of technological advancements, enabling clients to tackle the ever-evolving challenges of bioproduction. As the global biopharmaceutical industry surges forward, driven by increasing demand for biologics, Sartorius Stedim Biotech remains poised to maintain its role as an indispensable ally to firms dedicated to transforming the health landscape through revolutionary therapies.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Dr. Rene Faber
CEO & DIrector
No Bio Available
Mr. Rainer Lehmann
CFO & Member of Executive Board
No Bio Available
Ms. Petra Muller
Head of Investor Relations
No Bio Available
Ms. Petra Kirchhoff
Head of Corporate Communications & IR
No Bio Available
Olivier Guitard
Head of Controlling BPS
No Bio Available

Contacts

Address
PACA
Aubagne
Zone Industrielle les Paluds Avenue de Jouques, Bp 1051, Aubagne Cedex
Contacts
+33442845600.0
www.sartorius.com